Barbara KressExecutive Director, Clinical Data Disclosure & Transparency at MSD
Barbara is the Executive Director of Clinical Data Disclosure and Transparency at Merck. She is responsible for registry and results disclosure, redaction operations, return of plain language summaries to patients and data sharing. She joined Merck 26 years ago as a clinical scientist working on the successful development and submission of several compounds. Barbara has worked in the transparency space exclusively since 2007. Prior to joining Merck, Barbara started her career as a critical care and emergency room nurse. She participates in several disclosure work streams, including PhRMA, EFPIA, Transcelerate, the Multi-Regional Clinical Trials (MRCT) Center at Brigham and Women’s Hospital and Harvard and is a member of the NLM Board of Regents Public Service Working Group on Clinicaltrials.gov modernization.